Versetti Family Office, led by Angel Versetti, invests in biotech startups focusing on telomerase and follistatin gene therapies, cellular reprogramming, and diagnostic tools to measure biological age, providing funding and strategic support to extend healthspan.

Key points

• Platform trials test telomerase and follistatin gene therapies aiming to extend telomere length and enhance muscle regeneration.
• Cellular reprogramming approaches rejuvenate cells, tracked by next-generation biological age diagnostics in real time.
• Pre-seed funding and operational support accelerate biotech startups developing AI-driven personalized medicine for healthspan extension.

Matter Bio has launched a comprehensive research collaboration uniting experts from elite institutions to decode the genetic basis of longevity through multi-omics and AI. Analyzing centenarians and long-lived species, the project aims to translate genome stability insights into actionable interventions.

The published IEEE research by Venkata Sai Swaroop Reddy, demonstrated at ICEC 2024, illustrates a significant evolution in cybersecurity. By integrating deep learning methods such as GANs, MLPs, and CNNs, his work achieves notable reductions in risk and cost. Results indicate a 65% drop in phishing and over 40% improvement in detection, shifting defenses from reactive to proactive.